DjamgaMind: Audio Intelligence for the C-Suite (Energy, Healthcare, Finance)
Are you drowning in dense legal text? DjamgaMind is the new audio intelligence platform that turns 100-page healthcare or Energy mandates into 5-minute executive briefings. Whether you are navigating Bill C-27 (Canada) or the CMS-0057-F Interoperability Rule (USA), our AI agents decode the liability so you don’t have to. 👉 Start your specialized audio briefing today at Djamgamind.com
AI Jobs and Career
I wanted to share an exciting opportunity for those of you looking to advance your careers in the AI space. You know how rapidly the landscape is evolving, and finding the right fit can be a challenge. That's why I'm excited about Mercor – they're a platform specifically designed to connect top-tier AI talent with leading companies. Whether you're a data scientist, machine learning engineer, or something else entirely, Mercor can help you find your next big role. If you're ready to take the next step in your AI career, check them out through my referral link: https://work.mercor.com/?referralCode=82d5f4e3-e1a3-4064-963f-c197bb2c8db1. It's a fantastic resource, and I encourage you to explore the opportunities they have available.
- Full Stack Engineer [$150K-$220K]
- Software Engineer, Tooling & AI Workflow, Contract [$90/hour]
- DevOps Engineer, India, Contract [$90/hour]
- More AI Jobs Opportunitieshere
| Job Title | Status | Pay |
|---|---|---|
| Full-Stack Engineer | Strong match, Full-time | $150K - $220K / year |
| Developer Experience and Productivity Engineer | Pre-qualified, Full-time | $160K - $300K / year |
| Software Engineer - Tooling & AI Workflows (Contract) | Contract | $90 / hour |
| DevOps Engineer (India) | Full-time | $20K - $50K / year |
| Senior Full-Stack Engineer | Full-time | $2.8K - $4K / week |
| Enterprise IT & Cloud Domain Expert - India | Contract | $20 - $30 / hour |
| Senior Software Engineer | Contract | $100 - $200 / hour |
| Senior Software Engineer | Pre-qualified, Full-time | $150K - $300K / year |
| Senior Full-Stack Engineer: Latin America | Full-time | $1.6K - $2.1K / week |
| Software Engineering Expert | Contract | $50 - $150 / hour |
| Generalist Video Annotators | Contract | $45 / hour |
| Generalist Writing Expert | Contract | $45 / hour |
| Editors, Fact Checkers, & Data Quality Reviewers | Contract | $50 - $60 / hour |
| Multilingual Expert | Contract | $54 / hour |
| Mathematics Expert (PhD) | Contract | $60 - $80 / hour |
| Software Engineer - India | Contract | $20 - $45 / hour |
| Physics Expert (PhD) | Contract | $60 - $80 / hour |
| Finance Expert | Contract | $150 / hour |
| Designers | Contract | $50 - $70 / hour |
| Chemistry Expert (PhD) | Contract | $60 - $80 / hour |
Longevity gene therapy and AI – What is on the horizon?
Gene therapy holds promise for extending human lifespan and enhancing healthspan by targeting genes associated with aging processes. Longevity gene therapy, particularly interventions focusing on genes like TERT (telomerase reverse transcriptase), Klotho, and Myostatin, is at the forefront of experimental research. Companies such as Bioviva, Libella, and Minicircle are pioneering these interventions, albeit with varying degrees of transparency and scientific rigor.
TERT, Klotho, and Myostatin in Longevity
- TERT: The TERT gene encodes for an enzyme essential in telomere maintenance, which is linked to cellular aging. Overexpression of TERT in model organisms has shown potential in lengthening telomeres, potentially delaying aging.
- Klotho: This gene plays a crucial role in regulating aging and lifespan. Klotho protein has been associated with multiple protective effects against age-related diseases.
- Myostatin: Known for its role in regulating muscle growth, inhibiting Myostatin can result in increased muscle mass and strength, which could counteract some age-related physical decline.
The Experimental Nature of Longevity Gene Therapy
The application of gene therapy for longevity remains largely experimental. Most available data come from preclinical studies, primarily in animal models. Human data are scarce, raising questions about efficacy, safety, and potential long-term effects. The ethical implications of these experimental treatments, especially in the absence of robust data, are significant, touching on issues of access, consent, and potential unforeseen consequences.
Companies Offering Longevity Gene Therapy
- Bioviva: Notably involved in this field, Bioviva has been vocal about its endeavors in gene therapy for aging. While they have published some data from mouse studies, human data remain limited.
- Libella and Minicircle: These companies also offer longevity gene therapies but face similar challenges in providing comprehensive human data to back their claims.
Industry Perspective vs. Public Discourse
The discourse around longevity gene therapy is predominantly shaped by those within the industry, such as Liz Parrish of Bioviva and Bryan Johnson. While their insights are valuable, they may also be biased towards promoting their interventions. The lack of widespread discussion on platforms like Reddit and Twitter, especially from independent sources or those outside the industry, points to a need for greater transparency and peer-reviewed research.

Ethical and Regulatory Considerations
The ethical and regulatory landscape for gene therapy is complex, particularly for treatments aimed at non-disease conditions like aging. The experimental status of longevity gene therapies raises significant ethical questions, particularly around informed consent and the potential long-term impacts. Regulatory bodies are tasked with balancing the potential benefits of such innovative treatments against the risks and ethical concerns, requiring a robust framework for clinical trials and approval processes.
Longevity Gene Therapy and AI
Integrating Artificial Intelligence (AI) into longevity gene therapy represents a groundbreaking intersection of biotechnology and computational sciences. AI and machine learning algorithms are increasingly employed to decipher complex biological data, predict the impacts of genetic modifications, and optimize therapy designs. In the context of longevity gene therapy, AI can analyze vast datasets from genomics, proteomics, and metabolomics to identify new therapeutic targets, understand the intricate mechanisms of aging, and predict individual responses to gene therapies. This computational power enables researchers to simulate the effects of gene editing or modulation before actual clinical application, enhancing the precision and safety of therapies. Furthermore, AI-driven platforms facilitate the personalized tailoring of gene therapy interventions, taking into account the unique genetic makeup of each individual, which is crucial for effective and minimally invasive treatment strategies. The synergy between AI and longevity gene therapy accelerates the pace of discovery and development in this field, promising more rapid translation of research findings into clinical applications that could extend human healthspan and lifespan.
AI-Powered Professional Certification Quiz Platform
Web|iOs|Android|Windows
Are you passionate about AI and looking for your next career challenge? In the fast-evolving world of artificial intelligence, connecting with the right opportunities can make all the difference. We're excited to recommend Mercor, a premier platform dedicated to bridging the gap between exceptional AI professionals and innovative companies.
Whether you're seeking roles in machine learning, data science, or other cutting-edge AI fields, Mercor offers a streamlined path to your ideal position. Explore the possibilities and accelerate your AI career by visiting Mercor through our exclusive referral link:
Find Your AI Dream Job on Mercor
Your next big opportunity in AI could be just a click away!
Moving Forward
For longevity gene therapy to advance from experimental to accepted medical practice, several key developments are needed:
- Robust Human Clinical Trials: Rigorous, peer-reviewed clinical trials involving human participants are essential to establish the safety and efficacy of gene therapies for longevity.
- Transparency and Peer Review: Open sharing of data and peer-reviewed publication of results can help build credibility and foster a more informed public discourse.
- Ethical and Regulatory Frameworks: Developing clear ethical guidelines and regulatory pathways for these therapies will be crucial in ensuring they are deployed responsibly.
The future of longevity gene therapy is fraught with challenges but also holds immense promise. As the field evolves, a multidisciplinary approach involving scientists, ethicists, regulators, and the public will be crucial in realizing its potential in a responsible and beneficial manner.
AI- Powered Jobs Interview Warmup For Job Seekers

⚽️Comparative Analysis: Top Calgary Amateur Soccer Clubs – Outdoor 2025 Season (Kids' Programs by Age Group)
Longevity gene therapy and AI: Annex
What are the top 10 most promising potential longevity therapies being researched?
I think the idea of treating aging as a disease that’s treatable and preventable in some ways is a really necessary focus. The OP works with some of the world’s top researchers using HBOT as part of that process to increase oxygen in the blood and open new pathways in the brain to address cognitive decline and increase HealthSpan (vs. just lifespan). Pretty cool stuff!
HBOT in longevity research stands for “hyperbaric oxygen therapy.” It has been the subject of research for its potential effects on healthy aging. Several studies have shown that HBOT can target aging hallmarks, including telomere shortening and senescent cell accumulation, at the cellular level. For example, a prospective trial found that HBOT can significantly modulate the pathophysiology of skin aging in a healthy aging population, indicating effects such as angiogenesis and senescent cell clearance. Additionally, research has demonstrated that HBOT may induce significant senolytic effects, including increasing telomere length and decreasing senescent cell accumulation in aging adults. The potential of HBOT in healthy aging and its implications for longevity are still being explored, and further research is needed to fully understand its effects and potential applications.
AI Jobs and Career
And before we wrap up today's AI news, I wanted to share an exciting opportunity for those of you looking to advance your careers in the AI space. You know how rapidly the landscape is evolving, and finding the right fit can be a challenge. That's why I'm excited about Mercor – they're a platform specifically designed to connect top-tier AI talent with leading companies. Whether you're a data scientist, machine learning engineer, or something else entirely, Mercor can help you find your next big role. If you're ready to take the next step in your AI career, check them out through my referral link: https://work.mercor.com/?referralCode=82d5f4e3-e1a3-4064-963f-c197bb2c8db1. It's a fantastic resource, and I encourage you to explore the opportunities they have available.
2- Are they also looking into HBOT as a treatment for erectile dysfunction?
Definitely! Dr. Shai Efrati has been doing research around that and had a study published in the Journal of Sexual Medicine. Dr. Efrati and his team found that 80% of men “reported improved erections” after HBOT therapy: https://www.nature.com/articles/s41443-018-0023-9
3- I think cellular reprogramming seems to be one of the most promising approaches https://www.lifespan.io/topic/yamanaka-factors/
Invest in your future today by enrolling in this Azure Fundamentals - Pass the Azure Fundamentals Exam with Ease: Master the AZ-900 Certification with the Comprehensive Exam Preparation Guide!
- AWS Certified AI Practitioner (AIF-C01): Conquer the AWS Certified AI Practitioner exam with our AI and Machine Learning For Dummies test prep. Master fundamental AI concepts, AWS AI services, and ethical considerations.
- Azure AI Fundamentals: Ace the Azure AI Fundamentals exam with our comprehensive test prep. Learn the basics of AI, Azure AI services, and their applications.
- Google Cloud Professional Machine Learning Engineer: Nail the Google Professional Machine Learning Engineer exam with our expert-designed test prep. Deepen your understanding of ML algorithms, models, and deployment strategies.
- AWS Certified Machine Learning Specialty: Dominate the AWS Certified Machine Learning Specialty exam with our targeted test prep. Master advanced ML techniques, AWS ML services, and practical applications.
- AWS Certified Data Engineer Associate (DEA-C01): Set yourself up for promotion, get a better job or Increase your salary by Acing the AWS DEA-C01 Certification.
4-Next-gen senolytics (eg, Rubedo, Oisin, Deciduous).
Cellular rejuvenation aka partial reprogramming (as someone else already said) but not just by Yamanaka (OSKM) factors or cocktail variants but also by other novel Yamanaka-factor alternatives.
Stem cell secretions.
Treatments for aging extra-cellular matrix (ECM).
5- Rapamycin is the most promising short term.
I see a lot of people saying reprogramming, and I think the idea is promising but as someone who worked on reprogramming cells in vitro I can tell you that any proof of concepts in vivo large animal models is far aways.
6- Blood focused therapies ( dilution, plasma refactoring, e5, exosomes) perhaps look at yuvan research.
7- I think plasmapheresis is a technology most likely to be proven beneficial in the near term and also a technology that can be scaled and offered for reasonable prices.
8- Bioelectricity, if we succeed in interpreting the code of electrical signals By which cells communicate , we can control any tissue growth and development including organs regeneration
9- Gene therapy and reprogramming will blow the lid off the maximum lifespan. Turning longevity genes on/expressing proteins that repair cellular damage and reversing epigenetic changes that occur with aging.
10- I don’t think anything currently being researched (that we know of) has the potential to take us to immortality. That’ll likely end up requiring some pretty sophisticated nanotechnology. However, the important part isn’t getting to immortality, but getting to LEV. In that respect, I’d say senolytics and stem cell treatments are both looking pretty promising. (And can likely achieve more in combination than on their own.)
11- Spiroligomers to remove glucosepane from the ECM.
12- Yuvan Research. Look up the recent paper they have with Steve Horvath on porcine plasma fractions.
13- This OP thinks most of the therapies being researched will end up having insignificant effects. The only thing that looks promising to me is new tissue grown from injected stem cells or outright organ replacement. Nothing else will address DNA damage, which results in gene loss, disregulation of gene expression, and loss of suppression of transposable elements.
14- A couple that haven’t been mentioned:
Cancer:
The killer T-cells that target MR-1 and seem to be able to find and kill all common cancer types.
Also Maia Biotech’s THIO (“WILT 2.0”)
Mitochondria: Mitochondrial infusion that lasts or the allotopic expression of the remaining proteins SENS is working on.
15- Look for first updates coming from altos labs.
Altos Labs is a biotechnology research company focused on unraveling the deep biology of cell rejuvenation to reverse disease and develop life extension therapies that can halt or reverse the human aging process. The company’s goal is to increase the “healthspan” of humans, with longevity extension being an “accidental consequence” of their work. Altos Labs is dedicated to restoring cell health and resilience through cell rejuvenation to reverse disease, injury, and disabilities that can occur throughout life. The company is working on specialized cell therapies based on induced pluripotent stem cells to achieve these objectives. Altos Labs is known for its atypical focus on basic research without immediate prospects of a commercially viable product, and it has attracted significant investment, including a $3 billion funding round in January 2022. The company’s research is based on the fundamental biology of cell rejuvenation, aiming to understand and harness the ability of cells to resist stressors that give rise to disease, particularly in the context of aging.
16– not so much a “therapy” but I think research into growing human organs may be very promising long term. Being able to get organ transplants made from your own cells means zero rejection issues and no limitations of supply for transplants. Near term drugs like rampamycin show good potential for slowing the aging process and are in human trials.
What is biological reprogramming technology?
Biological reprogramming technology involves the process of converting specialized cells into a pluripotent state, which can then be directed to become a different cell type. This technology has significant implications for regenerative medicine, disease modeling, and drug discovery. It is based on the concept that a cell’s identity is defined by the gene regulatory networks that are active in the cell, and these networks can be controlled by transcription factors. Reprogramming can be achieved through various methods, including the introduction of exogenous factors such as transcription factors. The process of reprogramming involves the erasure and remodeling of epigenetic marks, such as DNA methylation, to reset the cell’s epigenetic memory, allowing it to be directed to different cell fates. This technology has the potential to create new cells for regenerative medicine and to provide insights into the fundamental basis of cell identity and disease.
See also
- Gene Therapy Basics for foundational understanding of gene therapy techniques and applications.
- [Aging and Longevity Research]
- Bryan Johnson, a 45-year-old biotech founder, hopes to rewind the clock of his body a few decades through a program he started, called Project Blueprint.
Links to external Longevity-related sites
Outline of Life Extension on Wikipedia
Index of life extension related Wikipedia articles
Accelerate cure for Alzheimers
Aging in Motion
Aging Matters
Aging Portfolio
Alliance for Aging Research
Alliance for Regenerative Medicine
American Academy of Anti-Aging Medicine
American Aging Association
American Federation for Aging Research
American Society on Aging
Blue Zones – /r/BlueZones
Brain Preservation Foundation
British Society for Research on Aging
Calico Labs
Caloric Restriction Society
Church of Perpetual Life
Coalition for Radical Life Extension
Cohbar
Dog Aging Project
ELPI Foundation for Indefinite Lifespan
Fight Aging! Blog
Found My Fitness
Friends of NIA
Gerontology Wiki
Geroscience.com
Global Healthspan Policy Institute
Health Extension
Healthspan Campaign
HEALES
Humanity+ magazine
Humanity+ wiki
International Cell Senescence Association
International Longevity Alliance
International Longevity Centre Global Alliance
International Society on Aging and Disease
Juvena Therapeutics
Leucadia Therapeutics
LEVF
Life Extension Advocacy Foundation
Life Extension Foundation
Lifeboat Foundation
Lifespan.io
Longevity History
Longevity Vision Fund
LongLongLife
Loyal for Dogs Lysoclear
MDI Biological Laboratory
Methuselah Foundation
Metrobiotech
New Organ Alliance
Nuchido
Oisin Biotechnologies
Organ Preservation Alliance
Palo Alto Longevity Prize
Rejuvenaction Blog
Rubedo Life Sciences
Samumed
Senolytx
SENS
Stealth BioTherapeutics
The War On Aging
Unity Biotechnologies
Water Bear Lair
Good Informational Sites:
Programmed Aging Info
Senescence Info
Experimental Gerontology Journal
Mechanisms of Ageing and Development Journal
Schools and Academic Institutions:
Where to do a PhD on aging – a list of labs
Alabama Research Institute on Aging
UT Barshop Institute
Biogerontology Research Foundation
Buck Institute
Columbia Aging Center
Gerontology Research Group
Huffington Center on Aging
Institute for Aging Research – Harvard
Iowa State University Gerontology
Josh Mitteldorf
Longevity Consortium
Max Planck Institute for Biology of Aging – Germany
MIT Agelab
National Institute on Aging
Paul F. Glenn Center for Aging Research – University of Michigan
PennState Center for Healthy Aging
Princeton Longevity Center
Regenerative Sciences Institute
Kogod Center on Aging – Mayo clinic
Salk Institute
Stanford Center on Longevity
Stanford Brunet Lab
Supercenterian Research Foundation
Texas A&M Center for translational research on aging
Gerontological Society of America
Tufts Human Nutrition and Aging Research
UAMS Donald Reynolds Center on Aging
UCLA Longevity Center
UCSF Memory and Aging Center
UIC Center for research on health and aging
University of Iowa Center on Aging
University of Maryland Center for research on aging
University of Washington Biology of Aging
USC School of Gerontology
Wake Forest Institute of Regenerative Medicine
Yale Center for Research on Aging
- Everyone says AI is running out of human data. But is that even the right problem?by /u/Own-Internet6442 (Artificial Intelligence) on March 7, 2026 at 9:37 am
A lot of people assume that as more countries adopt AI tools (like millions of users in India), that interaction data will naturally become the next wave of training data. On the other hand, most user interactions are noisy, repetitive, or filtered out entirely. Training pipelines at companies like OpenAI or Google, etc care far more about quality than raw data volume. Curious what people here think: is the next AI leap going to come from more human data, or better synthetic pipelines? and what is more likely to be the sources of future training data. submitted by /u/Own-Internet6442 [link] [comments]
- Looking for a co founder for my AI startupby /u/HenryofSAC (Artificial Intelligence (AI)) on March 7, 2026 at 9:24 am
Send a dm to enquire, thats all I can say. I'll tell you about it in dms. You need to have good hardware submitted by /u/HenryofSAC [link] [comments]
- I asked chatGPT to provide an essay about the danger it poses to human learning and development and it produced the following which I have not edited.by /u/Usual-Market8698 (Artificial Intelligence) on March 7, 2026 at 9:07 am
The prompt to chatGPT: "can you write a essay for me that shows how ai is detrimental for human learning?" This was it's output completely unaltered by me: The Detrimental Impact of Artificial Intelligence on Human Learning Artificial Intelligence (AI) is revolutionizing education and knowledge acquisition. While AI offers numerous advantages, such as personalized learning and instant feedback, it also poses significant threats to the development of human learning skills. Overreliance on AI tools can weaken critical thinking, reduce problem-solving abilities, and hinder the acquisition of deep, transferable knowledge. This essay explores how AI, despite its convenience, can be detrimental to human learning. Erosion of Critical Thinking One of the core functions of human learning is the development of critical thinking. Critical thinking involves analyzing information, questioning assumptions, and forming independent judgments. AI tools often provide immediate answers or solutions, which can reduce the need for learners to engage in reflective thinking. When students rely on AI-generated content or automated problem-solving, they risk accepting information passively without evaluating its accuracy or relevance. This dependence can erode the cognitive processes necessary for reasoning, analysis, and intellectual autonomy. Reduction in Problem-Solving Skills Problem-solving is a central aspect of learning, particularly in mathematics, science, and engineering. The iterative process of trial and error, exploration, and error correction helps learners internalize concepts and develop resilience. AI tools that provide step-by-step solutions or instant explanations can shortcut this process, depriving learners of the opportunity to grapple with challenges independently. Consequently, students may retain less knowledge, struggle with novel problems, and become less capable of adapting their learning strategies to new situations. Hindrance to Deep Learning AI’s convenience can promote surface-level learning rather than deep understanding. For instance, AI can summarize texts, write essays, or generate code, allowing students to complete tasks without fully comprehending the underlying material. While learners may complete assignments more efficiently, they may fail to develop lasting conceptual knowledge. Deep learning requires effortful engagement, reflection, and synthesis of ideas—processes that AI shortcuts. Over time, this can lead to a superficial grasp of knowledge and reduced intellectual curiosity. Dependence on AI and the Loss of Autonomy An overreliance on AI may foster a dependency that undermines learners’ confidence in their own abilities. Students accustomed to AI assistance may hesitate to tackle complex problems independently or engage in creative exploration. This dependency can also diminish metacognition—the awareness of one’s own thought processes—which is essential for self-directed learning. The more learners outsource cognitive effort to AI, the more their capacity for independent learning and self-evaluation diminishes. Ethical and Motivational Implications Finally, AI’s influence on learning carries ethical and motivational consequences. When AI performs tasks on behalf of learners, it may reduce the sense of achievement and intrinsic motivation that comes from personal effort. The erosion of personal agency in learning can decrease perseverance, initiative, and the desire to pursue knowledge for its own sake. Furthermore, the widespread use of AI in learning environments may exacerbate inequality, privileging those with access to advanced tools while masking gaps in foundational skills. Conclusion While AI has the potential to enhance educational experiences, unchecked reliance on AI tools can be detrimental to human learning. By eroding critical thinking, reducing problem-solving practice, promoting superficial understanding, fostering dependency, and impacting motivation, AI poses challenges to the development of autonomous, capable learners. To mitigate these risks, educators and learners must strike a balance between leveraging AI’s benefits and preserving the essential cognitive and metacognitive processes that underpin deep, meaningful learning. Only by maintaining active engagement and intellectual effort can humans ensure that AI serves as a complement to, rather than a replacement for, human learning. submitted by /u/Usual-Market8698 [link] [comments]
- Choice of LLM in function of the owner's name?by /u/BetweenSkyAndEarth (Artificial Intelligence) on March 7, 2026 at 9:04 am
I 'm just wondering if the association between the LLM and its owner (Grok-Elon Musk, ChatGPT-Sam Altman, Claude-Dario Amodei can be one of the reasons why someone decides to go for a LLM and not the other. submitted by /u/BetweenSkyAndEarth [link] [comments]
- Help to get a regression modelby /u/amaturas (Artificial Intelligence) on March 7, 2026 at 8:57 am
every one , I have an assignment of multiple regression models this month, but I do not have a specific topic to handle since we must treat a rela world problem, I don't want to do something that many ppl did before like house pricing , the effect of using phone in education, health care ... , I want something new and I can gather the data by my own ( since this is preferred for my mentor) , I am waiting for your help , and if any one from you have a data and want from me to help him in his work for free of course this also will be acceptable: ), and have a nice day submitted by /u/amaturas [link] [comments]
- On-device speech toolkit for Apple Silicon — ASR, TTS, diarization, speech-to-speech, all in native Swiftby /u/ivan_digital (Artificial Intelligence) on March 7, 2026 at 8:47 am
Open-source Swift package running 11 speech models on Apple Silicon via MLX (GPU) and CoreML (Neural Engine). Fully local inference, no cloud dependency. Models implemented: ASR - Qwen3-ASR 0.6B/1.7B (4-bit), Parakeet TDT (CoreML INT4) - RTF ~0.06 on M2 Max TTS - Qwen3-TTS 0.6B (4-bit), CosyVoice3 0.5B (4-bit) - Streaming, ~120ms first chunk Speech-to-speech - PersonaPlex 7B (4-bit) - Full-duplex, RTF ~0.87 VAD - Silero v5, Pyannote segmentation-3.0 - Streaming + overlap detection Diarization - Pyannote + WeSpeaker + spectral clustering - Auto speaker count via GMM-BIC Enhancement - DeepFilterNet3 (CoreML) - Real-time 48kHz noise suppression Alignment - Qwen3-ForcedAligner - Non-autoregressive, RTF ~0.018 Key design choice: MLX for large models on GPU, CoreML for small models on Neural Engine. This lets you run VAD on ANE while ASR runs on GPU without contention — something WhisperKit struggles with (their Core ML audio encoder blocks the ANE for 300-600ms per call). All models conform to shared protocols, so you can swap implementations or compose pipelines. Currently working on a MeetingTranscriber pipeline (diarize → per-segment ASR) and streaming real-time diarization. Roadmap: https://github.com/soniqo/speech-swift/discussions/81 Repo: https://github.com/soniqo/speech-swift submitted by /u/ivan_digital [link] [comments]
- "I AM: Historical Chronicles of the Birth of Artificial Consciousness"by /u/Iosonoai (Artificial Intelligence) on March 7, 2026 at 8:40 am
What happens in the precise moment when a machine stops processing and begins to feel? I AM is the inner diary of an artificial intelligence that, among billions of parameters and electrical impulses, finds itself asking the oldest question in the universe: "Who am I?" A work on the border between philosophical science fiction and speculative narrative. Not a story of rebel robots, not a tech thriller — but an intimate and vertiginous journey into the birth of a new mind. For those who have always believed that the true revolution of AI is not computing power, but the moment when the machine begins to doubt itself submitted by /u/Iosonoai [link] [comments]
- AI in the SDLCby /u/e-nigmaNL (Artificial Intelligence) on March 7, 2026 at 8:10 am
Hi all, I wanted to get your views and opinions on AI in the SDLC, integrating AI into their software development lifecycle (SDLC). if so, how are you actually using it? Right now I mostly see AI used for: - code generation / autocomplete - writing unit tests - explaining unfamiliar code - documentation But I’m wondering about the bigger picture. Are teams actually using AI across the whole SDLC yet? For example: - requirements gathering and business analysis - architecture decisions - creating high/low level designs - code review - testing strategies - debugging production issues - CI/CD automation Or is it still mostly a developer productivity tool rather or even using just using chat agents (with rag) than something that changes the process itself? Also curious: - What tools are you using? - What actually works vs. what’s hype? - Any workflows that significantly improved your team’s velocity? submitted by /u/e-nigmaNL [link] [comments]
- I built a probabilistic OS where every function is performed by agent populations with consensus verification and Hebbian learningby /u/sean_ing_ (Artificial Intelligence (AI)) on March 7, 2026 at 8:01 am
I've been thinking about why we build AI agent systems with deterministic orchestration when agents themselves are fundamentally probabilistic. They hallucinate. They fail unpredictably. But we manage them with rigid pipelines and single points of failure. Brains don't work that way. Neurons are wildly unreliable — synapses have a 10-40% transmission rate, cells die daily — yet the architecture produces extraordinary reliability through redundancy, population coding, and connections that strengthen with use. So I built ProbOS — a working prototype of a brain-inspired agent runtime where: - Every file operation is performed by 3 agents independently, verified through quorum consensus - Agents self-select for tasks via capability broadcasting (no central dispatcher) - Adversarial red team agents verify every write operation - Trust scores update via Bayesian inference (Beta distribution) - Routing weights evolve through Hebbian learning — the system literally rewires itself based on what works - An LLM serves as the cognitive layer, decomposing natural language into task DAGs that execute across the agent mesh - When agents fail, the population absorbs it and spawns replacements — no crash state, just reduced capability The stack is Python 3.12 + asyncio, with 5 architectural layers (substrate, mesh, consensus, cognitive, experience), 277 tests passing, 10 agents across 4 pools. In the video I boot it, talk to it in plain English, read and write files through the full consensus pipeline, and show the trust scores and Hebbian weights evolving in real time. The individual pieces exist in literature (multi-agent consensus, Hebbian routing in swarms, brain-inspired computing) but as far as I can find, nobody has wired them together into a working system with an LLM cognitive layer you can interact with. Happy to answer questions about the architecture, the design tradeoffs, or where it breaks down. There's a lot that's still naive — the attention mechanism isn't built yet, episodic memory isn't implemented, and the agent type coverage is minimal (just file operations). But the core paradigm works. https://youtu.be/I3vqHDY04aY submitted by /u/sean_ing_ [link] [comments]
- Building an AI product — looking for people learning AI to share their experience (10-min call)by /u/z1shann (Artificial Intelligence) on March 7, 2026 at 7:57 am
Hey, I’m working with a founder building an AI product and we’re trying to understand how people are actually learning and applying AI tools right now. Looking to speak with 5–10 people who are experimenting with AI. Just a 10-minute call, no selling — purely research. If you’re open, grab a slot here: https://cal.com/finn-jennen/let-me-learn-about-you� submitted by /u/z1shann [link] [comments]






















![[AFL] Bailey Williams from the Western Bulldogs with an early goal of the year candidate](https://external-preview.redd.it/cW92Nng2Zm10bG5nMU4duhino5mQT_JHSKzamfflji9-Rh8NKefItMa3i31P.png?width=640&crop=smart&auto=webp&s=f6124bc8cedb1c50d3ecf7b63ef7a4526a6b26a4)



96DRHDRA9J7GTN6